Accelerating Drug Discovery through digital and AI innovations
Wednesday, 15 September 2021, 9.15am to 12pm
This event by the BIA Science and Innovation Advisory Committee (SIAC) will help SMEs involved in discovering new therapies and diagnostics understand how they can benefit from digital tools and innovations to accelerate R&D, reduce the risks, and transform their businesses.
Emerging data technologies and AI are already identifying the drivers behind disease and discovering new approaches to diagnose and treat those diseases. Case studies will be presented from organisations that have successfully used AI and digital tools in discovery, covering data generation, manipulation, and application. Further workshops are likely to follow on topics identified by attendees, so please do share your thoughts on how we can support you in this area.
Agenda
09:15 Sign in and networking
09:30 Welcome
Justin Bryans, LifeArc
09:35 Data application - example 1
Dan Jamieson, Biorelate
09:50 Data application - example 2
10:05 Data generation and access
Rafael Jimenez, Medicines Discovery Catapult
10:20 Data-driven computational approaches for identifying novel therapeutic targets and drug repositioning opportunities
Namshik Han, Milner Therapeutics Institute, University of Cambridge
10:35 Break
10:50 Live Q&A and panel discussion - chaired by Karen Wilkinson (KTN) and Liliya Serazetdinova (Earlham Institute)
Dan Jamieson, Biorelate
Rafael Jimenez, Medicines Discovery Catapult
Namshik Han, Milner Institute
Richard Goodwin, AstraZeneca
11:50 Summary and closing remarks
Justin Bryans, LifeArc